Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia

Waled Bahaj; Tariq Kewan; Carmelo Gurnari; Arda Durmaz; Ben Ponvilawan; Ishani Pandit; Yasuo Kubota; Olisaemeka Ogbue; Misam Zawit; Yazan F. Madanat; Taha Bat; Suresh Kumar Balasubramanian; Hussein Awada; Ramsha Ahmed; Minako Mori; Manja Meggendorfer; Torsten Haferlach; Valeria Visconte; Jaroslaw P. Maciejewski

doi:10.1186/s13045-023-01480-y

Abstract

Our novel approach more accurately resolves TP53 genomic configuration and uncovers genetic mosaicism for the use in the clinical setting to improve prognostic evaluation.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bahaj et al. (2023) studied this question.

synapsesocial.com/papers/69d80a6bfc5937d393ae2bbe https://doi.org/10.1186/s13045-023-01480-y

View Full Paper

Ask AI

Bookmark

Share

Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia

Abstract

Discussion

Cite This Study

Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia

Abstract

Discussion

Cite This Study

Keep reading

Keep reading